Legal and Regulatory Standards Sample Clauses

Legal and Regulatory Standards. Institution shall perform and shall ensure that all Study Personnel perform the Study at the Study Site, which is Haematology-Oncology Clinic in strict compliance with:
AutoNDA by SimpleDocs
Legal and Regulatory Standards. The parties will conduct each Study in accordance with all applicable laws, other applicable regulations, esp. with Medical Devices Act and Act 89/2012 Coll., Civil Code and international standards, including but not limited to International Conference on Harmonization, Good Clinical Practice (ICH‐GCP), the Declaration of Helsinki, ISO 14155:2011, the regulations of the United States Food and Drug Administration or its foreign equivalent governing clinical investigations and the protection of human subjects (“Applicable Law”). Xxxxxx is responsible (prior to starting any Study) for applying for approval from the responsible EC and, if applicable, from the responsible higher competent authority (“CA“), i.e. State Institute for Drug Control. Xxxxxx is responsible for all costs incurred in obtaining the approvals. 4.1 Zákonné a regulační normy. Strany budou provádět každou Studii v souladu se všemi příslušnými právními předpisy, zejména zákonem o zdravotních prostředcích a zák. č. 89/2012 Sb., občanský zákoník, a mezinárodními normami, včetně mimo jiné Mezinárodní konference o harmonizaci dobré klinické praxe (International Conference on Harmonization, Good Clinical Practice, ICH‐GCP), Helsinské deklarace, normy ISO 14155: 2011, předpisů Úřadu pro kontrolu potravin a léčiv USA nebo jeho ekvivalentu v zahraničí, které upravují klinická hodnocení a ochranu jejich subjektů (xxxx xxx „příslušné právní předpisy“). Společnost Xxxxxx xx povinna před zahájením každé Studie získat souhlas Etické komise a povolení příslušné autority, tedy Státního ústavu pro kontrolu léčiv. Náklady pro získání těchto povolení nese společnost Abbott. CONFIDENTIAL DŮVĚRNÉ MCSA EMEA MCSA EMEA
Legal and Regulatory Standards. The parties will conduct each Study in accordance with all applicable laws, regulations and international standards, including but not limited to International Conference on Harmonization, Good Clinical Practice (ICH-GCP), the Declaration of Helsinki, ISO 14155, the regulations of the United States Food and Drug Administration or its foreign equivalent governing clinical investigations and the protection of human subjects (“Applicable Law”).
Legal and Regulatory Standards a. Supplier represents and warrants that it complies with, and that throughout the term of this InfoSec Agreement and any other Agreement it will continue to comply with, all Applicable Laws. Supplier acknowledges and agrees that Supplier is solely responsible for determining Applicable Laws, and Supplier is not relying in any manner on Client in this regard. This compliance covenant is in addition to Supplier’s obligations set forth in Appendix A to this InfoSec Agreement (Supplier Security Obligations). b. If Supplier receives, processes, transmits or stores any Cardholder Data for or on behalf of Client, Supplier represents and warrants that information security procedures, processes, and systems will at all times meet or exceed all applicable information security laws, standards, rules, and requirements related to the collection, storage, processing, and transmission of payment card information, including those established by applicable governmental regulatory agencies, the Payment Card Industry (the “PCI”), all applicable networks, and any written standards provided by Client’s information security group to Supplier from time to time (all the foregoing collectively the “PCI Compliance Standards”). c. If Supplier Processes Protected Health Information, the terms and conditions of Client’s Business Associate Agreement will apply to the Processing of such data. d. If neither Applicable Laws nor this InfoSec Agreement specifically address a particular data security or privacy issue, Supplier will use appropriate, Generally Accepted Practices to protect the confidentiality, security, privacy, integrity, availability, and accuracy of the potentially affected Personal Data. e. Supplier agrees that, in the event of a breach of this InfoSec Agreement, neither Client nor any relevant Client customer will have an adequate remedy in damages. Client or an affected customer shall therefore be entitled to seek injunctive or equitable relief to immediately cease or prevent the further use or disclosure of Personal Data and ensure compliance with all Applicable Laws. f. In the event and to the extent that the Applicable Laws impose stricter obligations on the Supplier than the express obligations under this InfoSec Agreement, Supplier shall comply with the obligations under the Applicable Laws.
Legal and Regulatory Standards. The parties will conduct each Study in accordance with all the laws and regulations applying to conduct of clinical trials in the Czech Republic, methodological instructions of the Ministry of Health and applicable national legislation and also in accordance with all applicable laws, regulations and international standards, including but not limited to International Conference on Harmonization, Good Clinical Practice (ICH-GCP), the Declaration of Helsinki, ISO 14155:2011, the regulations of the United States Food and Drug Administration or its foreign equivalent governing clinical investigations and the protection of human subjects (“Applicable Law”). 4.1 Zákonné a regulační normy Strany budou provádět každou Studii v souladu se všemi zákony a předpisy, které se vztahují na provádění klinických hodnocení v České republice, metodickými pokyny Ministerstva zdravotnictví a platnou vnitrostátní legislativou a xxxx v souladu se všemi platnými zákony, předpisy a mezinárodními normami, včetně mimo jiné Mezinárodní konference o harmonizaci dobré klinické praxe (International Conference on Harmonization, Good Clinical Practice, ICH- GCP), Helsinské deklarace, normy ISO 14155: 2011, předpisů Úřadu pro kontrolu potravin a léčiv USA nebo jeho ekvivalentu v zahraničí, upravující klinická hodnocení a ochranu lidských subjektů (xxxx xxxPlatné zákony“).

Related to Legal and Regulatory Standards

  • Legal and Regulatory Compliance ‌ 4.22.1 During the term of this Contract, Contractor must comply with all local, state, and federal licensing, accreditation and registration requirements/standards, necessary for the performance of this Contract and all other applicable federal, state and local laws, rules, and regulations. 4.22.2 While on the HCA premises, Contractor must comply with HCA operations and process standards and policies (e.g., ethics, Internet / email usage, data, network and building security, harassment, as applicable). HCA will make an electronic copy of all such policies available to Contractor. 4.22.3 Failure to comply with any provisions of this section may result in Contract termination.

  • Legal and Regulatory Actions Contractor represents and warrants that it is not aware of and has received no notice of any court or governmental agency proceeding, investigation, or other action pending or threatened against Contractor or any of the individuals or entities included in numbered paragraph 1 of these Contract Affirmations within the five (5) calendar years immediately preceding execution of this Contract or the submission of any related Solicitation Response that would or could impair Contractor’s performance under this Contract, relate to the contracted or similar goods or services, or otherwise be relevant to System Agency’s consideration of entering into this Contract. If Contractor is unable to make the preceding representation and warranty, then Contractor instead represents and warrants that it has provided to System Agency a complete, detailed disclosure of any such court or governmental agency proceeding, investigation, or other action that would or could impair Contractor’s performance under this Contract, relate to the contracted or similar goods or services, or otherwise be relevant to System Agency’s consideration of entering into this Contract. In addition, Contractor acknowledges this is a continuing disclosure requirement. Contractor represents and warrants that Contractor shall notify System Agency in writing within five (5) business days of any changes to the representations or warranties in this clause and understands that failure to so timely update System Agency shall constitute breach of contract and may result in immediate contract termination.

  • Safety Standards Performance of the Contract for all commodities or contractual services must comply with requirements of the Occupational Safety and Health Act and other applicable State of Florida and federal requirements.

  • OMB Standards Unless specified otherwise within this agreement, the Subrecipient shall procure all materials, property, or services in accordance with the requirements of 24 CFR 84.40−48.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials, and other studies (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement or the Prospectus were and, if still pending, are being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is accurate and complete in all material respects and fairly presents the data derived from such studies, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”); neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.

  • Environmental and Social Standards 1. The Project Implementing Entity shall ensure that its Respective Part of the Project is carried out in accordance with the Environmental and Social Standards, in a manner acceptable to the Bank. 2. Without limitation upon paragraph 1 above, the Project Implementing Entity shall ensure that its Respective Part of the Project is implemented in accordance with the respective Environmental and Social Commitment Plan (“ESCP”), in a manner acceptable to the Bank. To this end, the Project Implementing Entity shall ensure that: (a) the measures and actions specified in the respective ESCP are implemented with due diligence and efficiency, and provided in the respective ESCP; (b) sufficient funds are available to cover the costs of implementing the respective ESCP; (c) policies and procedures are maintained, and qualified and experienced staff in adequate numbers are retained to implement the respective ESCP, as provided in the respective ESCP; and (d) the respective ESCP, or any provision thereof, is not amended, repealed, suspended or waived, except as the Bank shall otherwise agree in writing, as specified in the respective ESCP, and ensure that the revised respective ESCP is disclosed promptly thereafter. 3. In case of any inconsistencies between the respective ESCP and the provisions of this Agreement, the provisions of this Agreement shall prevail. 4. The Project Implementing Entity shall ensure that: (a) all measures necessary are taken to collect, compile, and furnish to the Bank through regular reports, with the frequency specified in the respective ESCP, and promptly in a separate report or reports, if so requested by the Bank, information on the status of compliance with the respective ESCP and the environmental and social instruments referred to therein, all such reports in form and substance acceptable to the Bank, setting out, inter alia: (i) the status of implementation of the respective ESCP; (ii) conditions, if any, which interfere or threaten to interfere with the implementation of the respective ESCP; and (iii) corrective and preventive measures taken or required to be taken to address such conditions; and (b) the Bank is promptly notified of any incident or accident related to or having an impact on the Project which has, or is likely to have, a significant adverse effect on the environment, the affected communities, the public or workers, including, in accordance with the respective ESCP, the environmental and social instruments referenced therein and the Environmental and Social Standards. 5. The Project Implementing Entity shall establish, publicize, maintain and operate an accessible grievance mechanism, to receive and facilitate resolution of concerns and grievances of Project-affected people, and take all measures necessary and appropriate to resolve, or facilitate the resolution of, such concerns and grievances, in a manner acceptable to the Bank. 6. The Project Implementing Entity shall ensure that all bidding documents and contracts for civil works under its Respective Part of the Project include the obligation of contractors, subcontractors and supervising entities to: (a) comply with the relevant aspects of the respective ESCP and the environmental and social instruments referred to therein; and (b) adopt and enforce codes of conduct that should be provided to and signed by all workers, detailing measures to address environmental, social, health and safety risks, and the risks of sexual exploitation and abuse, sexual harassment and violence against children, all as applicable to such civil works commissioned or carried out pursuant to said contracts.

  • Quality Standards Each Party agrees that the nature and quality of its products and services supplied in connection with the other Party's Marks will conform to quality standards set by the other Party. Each Party agrees to supply the other Party, upon request, with a reasonable number of samples of any Materials publicly disseminated by such Party which utilize the other Party's Marks. Each Party will comply with all applicable laws, regulations, and customs and obtain any required government approvals pertaining to use of the other Party's marks.

  • Ethical Standards ‌ 7.8.1 Within ninety (90) days after the Effective Date, Developer shall adopt written policies establishing ethical standards of conduct for all Developer-Related Entities, including Developer’s supervisory and management personnel, in dealing with (a) IFA and the Department and (b) employment relations. Such policy shall be subject to review and comment by IFA prior to adoption. Such policy shall include standards of ethical conduct concerning the following: 7.8.1.1 Restrictions on gifts and contributions to, and lobbying of, IFA, the Department and any of their respective members, commissioners, directors, officers and employees, and elected State officials; 7.8.1.2 Protection of employees from unethical practices in selection, use, hiring, compensation or other terms and conditions of employment, or in firing, promotion and termination of employees; 7.8.1.3 Protection of employees from retaliatory actions (including discharge, demotion, suspension, threat, harassment, pay reduction or other discrimination in the terms and conditions of employment) in response to reporting of illegal (including the making of a false claim), unethical or unsafe actions or failures to act by any Developer-Related Entity; 7.8.1.4 Restrictions on directors, members, officers or supervisory or management personnel of any Developer-Related Entity engaging in any transaction or activity, including receiving or offering a financial incentive, benefit, loan or other financial interest, that is, or to a reasonable person appears to be, in conflict with or incompatible with the proper discharge of duties or independence of judgment or action in the performance of duties, or adverse to the interests of the Project or employees; 7.8.1.5 Restrictions on use of office or job position for a purpose that is, or would to a reasonable person appear to be, primarily for the private benefit of a director, member, officer or supervisory or management person, rather than primarily for the benefit of Developer or the Project, or primarily to achieve a private gain or an exemption from duty or responsibility for a director, member, officer or supervisory or management person; and 7.8.1.6 Restrictions on directors, members, officers or employees of any Developer-Related Entity performing any of the Work if the performance of such services would be prohibited under IFA’s conflict of interest rules and policies. 7.8.2 Developer shall cause its directors, members, officers and supervisory and management personnel, and require those of all other Developer-Related Entities, to adhere to and enforce the adopted policy on ethical standards of conduct. Developer shall establish reasonable systems and procedures to promote and monitor compliance with the policy. 7.8.3 Notwithstanding the foregoing in this Section 7.8, Developer has an affirmative obligation under this Agreement to disclose to IFA and to the Indiana State Ethics Commission when an interested party is or becomes an employee of IFA or the State. This obligation extends only to those facts that Developer knows or reasonably could know. For purposes of this Section 7.8.3, “interested party” means (a) the individual executing this Agreement, (b) an individual who has an interest of three percent (3%) or more of Developer, (c) any member of the immediate family of an individual specified in clause (a) or (b). For purposes of the preceding sentence, “immediate family” means the spouse and the unemancipated children of an individual.‌

  • Statutory and Regulatory Compliance Contractor shall comply with all laws and regulations applicable to the Community Development Block Grant-Disaster Recovery funds appropriated by the Disaster Relief Appropriations Act, 2013 (Pub. L. 113-2), including but not limited to the applicable Office of Management and Budget Circulars, which may impact the administration of funds and/or set forth certain cost principles, including the allowability of certain expenses.

  • Standards Compliance Registry Operator shall comply with relevant existing RFCs and those published in the future by the Internet Engineering Task Force (IETF), including all successor standards, modifications or additions thereto relating to the DNS and name server operations including without limitation RFCs 1034, 1035, 1123, 1982, 2181, 2182, 2671, 3226, 3596, 3597, 4343, and 5966. DNS labels may only include hyphens in the third and fourth position if they represent valid IDNs (as specified above) in their ASCII encoding (e.g., “xn--ndk061n”).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!